Bootcamp During Neoadjuvant Chemotherapy for Breast Cancer
Completed · Not applicable
Conditions studied: Breast Cancer
In brief
This is a randomized, single-site pilot study incorporating one control group. This research involves an exercise group and a non-exercise group (control group). The patients who are in the exercise group will be enrolled in the Dallas County Women's Adventure Boot Camp. This will require them to undergo exercise training 3 times per week, under the direction of an experienced personal trainer in a group setting. All Boot Camp personal trainers are trained in basic cardiac life support (CPR) and are trained to watch for any signs or symptoms associated with a poor exercise response. The investigators hypothesize that randomizing women to a supervised exercise program of core conditioning, muscular/circuit training, and short distance running administered during neoadjuvant chemotherapy for breast cancer can be performed. Patients will continue on study as they are undergoing neoadjuvant chemotherapy for their breast cancer. This will be about 4 - 6 months.
Key facts
- Study ID
- NCT01411787
- Run by
- University of Texas Southwestern Medical Center
- People needed
- 11
- Starts
- 2009-03-01
- Expected to finish
- 2018-04-03
- Last updated by the study team
- 2018-05-11
Who can join
Age: 18 and older, up to 70. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Receiving neoadjuvant chemotherapy for breast cancer at one of the UT Southwestern hospitals or affiliates (Simmons Cancer Center, Parkland Hospital)
- No evidence of metastatic disease as confirmed by routine staging
- 18 - 70 year old female
- Karnofsky score >80%
- Body Mass Index >25 kg/m2
- Able to speak, read and understand the English language
- Ability to understand and willingness to sign a written informed consent document
- All races and ethnicities will be eligible.
You may not qualify if…
- Unable to speak, read and understand the English language
- Patients may not be involved in other trials evaluating the efficacy of neoadjuvant therapy
- Insulin-dependent diabetic patients.
- Known to be pregnant or planning to become pregnant during the study.
- Subjects are prohibited from being on other cancer treatments aside from what their treating medical oncologist has prescribed, primarily additional chemotherapies.
Where it is running
- UT Southwestern Medical Center — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.